World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00523354
Date of registration: 30/08/2007
Prospective Registration: No
Primary sponsor: Swiss EE Study Group
Public title: Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis IEE
Scientific title: Phase 2 Proof-of-Concept Study to Analyze the Efficacy of in TNF-Alpha Blockade in Adult Patients With Severe, Corticosteroid-Dependent Eosinophilic Esophagitis
Date of first enrolment: August 2007
Target sample size:
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00523354
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 2
Countries of recruitment
Switzerland
Contacts
Name:     Hans-Uwe Simon, MD and PhD
Address: 
Telephone:
Email:
Affiliation:  Deaprtment of Pharmacology, University Bern, Bern, Switzerland
Key inclusion & exclusion criteria

Inclusion Criteria:

- Adult patients with severe, corticosteroid-dependent eosinophilic esophagitis

Exclusion Criteria:

- Pregnancy

- Evidence of latent or active tuberculosis

- Other contra-indications for TNF-alpha blockers

- Unstable medical conditions

- Malignancies



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Esophagitis
Intervention(s)
Drug: Infliximab
Primary Outcome(s)
Tissue eosinophilia before and after therapy
Secondary Outcome(s)
Secondary ID(s)
Swiss EE-Study Group
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history